谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Primary Results from Phase 3, Double-Blind, Placebo-Controlled SHINE Trial: Ibrutinib (Ibr) in Combination with Bendamustine-Rituximab (BR) and R-Maintenance as First-Line Treatment (1L) in Elderly Patients with Mantle Cell Lymphoma (MCL)

M. Dreyling,W. Jurczak,M. Jerkeman,J. Trotman,P. L. Zinzani,D. Belada,C. Boccomini,I. W. Flinn,P. Giri,A. Goy, P. A. Hamlin,O. Hermine,J. -A Hernandez-Rivas, X. Hong, S. J. Kim, D. Lewis, Y. Mishima, M. Oezcan,G. F. Perini,C. Pocock, Y. Song,S. E. Spurgeon, J. M. Storring,J. Walewski, J. Zhu, R. Qin,T. Henninger, S. Deshpande,A. Howes,Gouill S. Le,M. L. Wang

ONCOLOGY RESEARCH AND TREATMENT（2022）

引用 0|浏览21
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要